Litcius/Paper detail

Identification of a new structural family of SGK1 inhibitors as potential neuroprotective agents

Inés Maestro, Enrique López Madruga, Patricia Boya, Ana Martı́nez

2023Journal of Enzyme Inhibition and Medicinal Chemistry13 citationsDOIOpen Access PDF

Abstract

SGK1 is a serine/threonine kinase involved in several neurodegenerative-related pathways such as apoptosis, neuroinflammation, ionic channel regulation, and autophagy, among others. Despite its potential role as a pharmacological target against this kind of diseases, there are no reported inhibitors able to cross the BBB so far, being a field yet to be explored. In this context, a structure-based virtual screening against this kinase was performed, pointing out the deazapurine moiety as an interesting and easy-to-derivatize scaffold. Moreover, these inhibitors are able to i) exert neuroprotection in an in vitro model of AD and ii) block mitophagy in a PRKN-independent manner, reinforcing the hypothesis of SGK1 inhibitors as neuroprotective chemical tools.

Topics & Concepts

NeuroprotectionMitophagyContext (archaeology)ChemistryNeuroinflammationSGK1AutophagyKinaseDrug discoveryVirtual screeningNeurosciencePharmacologyComputational biologyBiochemistryBiologyApoptosisInflammationPaleontologyImmunologyNeuroscience and Neuropharmacology ResearchReceptor Mechanisms and SignalingNuclear Receptors and Signaling
Identification of a new structural family of SGK1 inhibitors as potential neuroprotective agents | Litcius